Skip to main content
. 2018 Feb 7;9:545. doi: 10.1038/s41467-018-02951-4

Fig. 3.

Fig. 3

SIRT5 promotes colorectal cancer cell growth dependent on its catalytic activity. a, b Western blotting confirming the stable expression of the control vector, FLAG-SIRT5 WT, or FLAG-SIRT5 H158Y in HCT116 (a) and LoVo (b) cells. c, d Growth curve of HCT116 (c) and LoVo (d) cells stably expressing the control vector (blue line), SIRT5 WT (red line), or SIRT5 H158Y (purple line). Data are the mean ± SD of five independent samples. ANOVA with Tukey’s test. ***P < 0.001. N.S. = not significant for the indicated comparison. e Representative wells of the clonogenic growth experiment of HCT116 and LoVo cells stably expressing the control vector, SIRT5 WT, or SIRT5 H158Y, respectively. f, g Quantified data of the clonogenic growth experiment in HCT116 (f) and LoVo(g) cells. Data are the mean ± SD of three independent samples. P values were calculated by ANOVA with Tukey’s test. **P < 0.01 and ***P < 0.001. N.S. = not significant for the indicated comparison